is tirzepatide no longer available Did the FDA Ban Compounded Semaglutide and Tirzepatide? Tirzepatide: How Does It Work

Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established cardiovascular disease

Its hard to find a space where someone isnt loudly sharing their non-medical opinion on GLP-1 weight loss while gleefully predicting (and sometimes wishing) long-lasting negative effects on its users

33,34 However, these studies are limited by the inability to identify NAION with electronic health record coding with absolute certainty

But what happens after that